Qube Research & Technologies (QRT)’s Eli Lilly LLY Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$131M	Sell	142,800 -61,700	-30%	-$62.6M	0.15%	158
2025 Q4	$220M	Sell	204,500 -34,200	-14%	-$32.7M	0.22%	82
2025 Q3	$182M	Buy	238,700 +22,700	+11%	+$16.9M	0.19%	119
2025 Q2	$168M	Buy	216,000 +25,900	+14%	+$20.1M	0.17%	135
2025 Q1	$157M	Buy	190,100 +85,300	+81%	+$71M	0.18%	132
2024 Q4	$80.9M	Buy	104,800 +10,000	+11%	+$8.28M	0.11%	237
2024 Q3	$84M	Buy	94,800 +39,900	+73%	+$35.9M	0.12%	187
2024 Q2	$49.7M	Sell	54,900 -59,400	-52%	-$47.5M	0.08%	293
2024 Q1	$88.9M	Buy	114,300 +49,800	+77%	+$35.4M	0.14%	177
2023 Q4	$37.6M	Buy	64,500 +45,900	+247%	+$26.8M	0.07%	326
2023 Q3	$9.99M	Buy	18,600 +12,200	+191%	+$6.29M	0.03%	646
2023 Q2	$3M	Buy	+6,400	New	+$2.68M	0.01%	880
2023 Q1	–	Sell	-30,000	Closed	-$11M	–	2823
2022 Q4	$11M	Hold	30,000	–	–	0.06%	461
2022 Q3	$9.7M	Buy	+30,000	New	+$9.51M	0.06%	425

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LLY Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Eli Lilly (LLY) stake by 265% in Q1 2026, buying an estimated $526M and bringing the position to 715,082 shares worth $658M. The position accounts for 0.73% of the portfolio, ranked #5.

Qube Research & Technologies (QRT) first reported a position in LLY in Q1 2018 and has held it in 27 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Qube Research & Technologies (QRT) held 715,082 shares of Eli Lilly worth $658M as of Q1 2026.
Qube Research & Technologies (QRT) bought 518,960 Eli Lilly shares in Q1 2026, an estimated $526M.
Eli Lilly made up 0.73% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #5 holding.
Qube Research & Technologies (QRT) first reported a position in Eli Lilly in Q1 2018 and has held it in 27 quarters since.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.